Daily BriefsECM

Daily Brief ECM: Alibaba Potential IPOs – Part 3 – An Early Look at Cloud and more

In today’s briefing:

  • Alibaba Potential IPOs – Part 3 – An Early Look at Cloud, Easy US$10bn+
  • Vedant Fashion OFS – Well Flagged and Recent Earnings Momentum Has Been Decent
  • Nexus Select Trust IPO Trading – Decent but Mostly Domestic Demand
  • DXN Holdings IPO Trading – Lukewarm Subscription Rates, Peers Have Corrected Since Last Note
  • PhilEnergy IPO Preview
  • AUB Group Placement – Came as a Surprise but Strong Track Record Makes up for It
  • Cognizant Technology Solutions: Launch of Cognizant Neuro AI Platform & Other Drivers
  • Incyte Corporation: New Approvals for Opzelura and Zynyz & Other Drivers
  • Marriott International Inc.: City Express & Digital Networks Driving Growth – Key Drivers
  • Full-Year Results for Alibaba’s CaiNiao: Reduced Losses, Slower Growth, and A (Likely) 2024 IPO

Alibaba Potential IPOs – Part 3 – An Early Look at Cloud, Easy US$10bn+

By Sumeet Singh

  • On 28th Mar 2023, Alibaba Group (9988 HK)  announced that it would adopt a new organizational and governance structure, splitting into six major business groups and other investments.
  • Alibaba also stated that each of the business groups would be set up as an independent entity with its own board and the groups will eventually seek to list.
  • In our previous note, we highlighted which division could list. In this note, we will look at the Cloud segement.

Vedant Fashion OFS – Well Flagged and Recent Earnings Momentum Has Been Decent

By Clarence Chu

  • Vedant Fashions (MANYAVAR IN)‘ Promoter is looking to raise US$239m via trimming a 7% stake in the firm. 
  • The selldown here is to meet the minimum public shareholding requirement of 25% set by SEBI.
  • The deal would be a large one to process with the base deal alone representing 187 days of the firm’s three month ADV.

Nexus Select Trust IPO Trading – Decent but Mostly Domestic Demand

By Sumeet Singh

  • Nexus Select Trust (NST IN) raised around US$391m in its India IPO. The market value of its assets stood at INR234bn (US$2.9bn), of which INR211bn (US$2.6bn) was from its retail assets.
  • NST is a REIT with a portfolio of 17 Grade A urban consumption centers. It is backed by Blackstone.
  • We have looked at various aspects of the deal in our previous note, in this note, we talk about the demand and trading dynamics.

DXN Holdings IPO Trading – Lukewarm Subscription Rates, Peers Have Corrected Since Last Note

By Clarence Chu

  • DXN Holdings (2080694D MK) raised around US$147m in its Malaysian IPO.
  • DXN Holdings (DXN) is a global health-oriented and wellness direct selling company.
  • In this note, we will talk about the trading dynamics.

PhilEnergy IPO Preview

By Douglas Kim

  • PhilEnergy is offering 2.8 million shares in the IPO and expected market cap range of the IPO is from 279 billion won to 318 billion won. 
  • The IPO price range is from 26,300 won to 30,000 won and the total offering amount is 74 billion to 84.4 billion won.
  • The company’s core products include stacking and laser notching equipment used in the rechargeable batteries manufacturing process. 

AUB Group Placement – Came as a Surprise but Strong Track Record Makes up for It

By Ethan Aw

  • AUB Group Limited (AUB AU) is looking to raise up to AUD150m (US$100m) in its primary placement. The proceeds will be used to strengthen its balance sheet.
  • The deal would be a large one to digest at 24 days of three month ADV and dilution of 6.2%.  
  • In this note, we’ll run the deal through our ECM framework and comment on deal dynamics.

Cognizant Technology Solutions: Launch of Cognizant Neuro AI Platform & Other Drivers

By Baptista Research

  • It was a successful first quarter for Cognizant Technology Solutions.
  • The adjusted operating margin for the first quarter was 14.6%, and the company had quarterly solid bookings growth of 28% YoY.
  • We give Cognizant Technology Solutions Corporation a ‘Hold’ rating with a revised target price.

Incyte Corporation: New Approvals for Opzelura and Zynyz & Other Drivers

By Baptista Research

  • Incyte had a terribly disappointing first quarter and failed to meet the revenue expectations as well as earnings expectations of Wall Street.
  • The company’s product revenue increased 14% year over year as Jakafi was in high demand among patients across all indications.
  • In hematology and oncology, the ongoing launches of Pemazyre and Minjuvi ex-U.S. were the primary factors in the 17% rise year over year.

Marriott International Inc.: City Express & Digital Networks Driving Growth – Key Drivers

By Baptista Research

  • Marriott International delivered a solid quarterly result that was an all-around beat resulting from strong demand growth globally, with a decent performance across all geographies and hotel levels.
  • U.S. and Canadian RevPAR increased by 26% year over year while occupancy increased by 8% to 66%.
  • Global card acquisitions climbed by 35% year on year, while global card expenditure increased by 16%.

Full-Year Results for Alibaba’s CaiNiao: Reduced Losses, Slower Growth, and A (Likely) 2024 IPO

By Daniel Hellberg

  • Cainiao Smart Logistics (1437124D HK) ‘s March 2023 quarterly and full-year results can be found within Alibaba’s full-year earnings report, which was released on Thursday May 18
  • In both the March quarter and its fiscal year, CaiNiao showed improved Adjusted EBITDA results, though in both periods the tech-centric logistics network still reported losses
  • Revenue growth slowed to 18% Y/Y in the March quarter, and parent Alibaba (ADR) (BABA US) indicated CaiNiao will target an IPO in 2024, a bit later than some expected

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars